Another COVID-19 death raises Olongapo toll to 54 | Inquirer News

Another COVID-19 death raises Olongapo toll to 54

OLONGAPO CITY—The city saw another COVID-19 death and five new cases on Monday (April 12), according to authorities.

Mayor Rolen Paulino Jr., in an advisory, said the new infections hit residents between the ages of 15 and 68 with the elderly suffering from pre-existing health conditions, like hypertension and diabetes.

Paulino said all of the patients displayed symptoms of COVID-19 and were immediately placed on quarantine while undergoing treatment.

Article continues after this advertisement

An elderly patient died after suffering from cardio-pulmonary arrest and multi-organ failure.

FEATURED STORIES

The 59-year-old fatality raised to 54 the total deaths recorded in the city that were related to COVID-19.

On April 11, the city recorded 18 new COVID-19 cases, which was one of its highest single-day record.

Article continues after this advertisement

TSB

Your subscription could not be saved. Please try again.
Your subscription has been successful.

Subscribe to our daily newsletter

By providing an email address. I agree to the Terms of Use and acknowledge that I have read the Privacy Policy.

For more news about the novel coronavirus click here.
What you need to know about Coronavirus.
For more information on COVID-19, call the DOH Hotline: (02) 86517800 local 1149/1150.

The Inquirer Foundation supports our healthcare frontliners and is still accepting cash donations to be deposited at Banco de Oro (BDO) current account #007960018860 or donate through PayMaya using this link.

TAGS: COVID-19, Death Toll, infections, Olongapo City, Regions

Your subscription could not be saved. Please try again.
Your subscription has been successful.

Subscribe to our newsletter!

By providing an email address. I agree to the Terms of Use and acknowledge that I have read the Privacy Policy.

© Copyright 1997-2024 INQUIRER.net | All Rights Reserved

This is an information message

We use cookies to enhance your experience. By continuing, you agree to our use of cookies. Learn more here.